Research Review Act of 2004

Bill: 108-hr-5213
Sponsor: Rep. Bilirakis, Michael [R-FL-9]
Introduced: 2004-10-05 in the House
Policy area: Health
Subjects: Ambulatory care
Clinical trials
Congress
Congressional investigations
Congressional reporting requirements
Digestive diseases
Epidemiology
Home care services
Medicaid
Medical research
Medicare
Nutrition
Old age, survivors and disability insurance
Paralysis
Research centers
Science, Technology, Communications
Social Welfare
Social security eligibility
Spinal cord injuries
Ulcers

Summary:
action_date: 2004-10-05
text: 
Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health, to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.
 
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.
 
Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.

action_date: 2004-10-07
text: 
Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health, to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.
 
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.
 
Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.

action_date: 2004-11-16
text: 

(This measure has not been amended since it was passed by the House on October 7, 2004. The summary of that version is repeated here.)

 
Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health, to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.
 
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.
 
Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.

action_date: 2004-11-30
text: 

(This measure has not been amended since it was passed by the House on October 7, 2004. The summary of that version is repeated here.)

 
Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health (NIH), to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.
 
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.
 
Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.


Legislative actions:
action_date: 2004-11-30
text: Became Public Law No: 108-427.
action_date: 2004-11-30
text: Became Public Law No: 108-427.
action_date: 2004-11-30
text: Signed by President.
action_date: 2004-11-30
text: Signed by President.
action_date: 2004-11-19
text: Presented to President.
action_date: 2004-11-19
text: Presented to President.
action_date: 2004-11-16
text: Message on Senate action sent to the House.
action_date: 2004-11-16
text: Passed Senate without amendment by Unanimous Consent. (consideration: CR S11389)
action_date: 2004-11-16
text: Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S11389)
action_date: 2004-10-08
text: Referred to the Subcommittee on Health.
action_date: 2004-10-08
text: Received in the Senate, read twice.
action_date: 2004-10-07
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2004-10-07
text: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504). (text: CR 10/6/2004 H8255)
action_date: 2004-10-07
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504).(text: CR 10/6/2004 H8255)
action_date: 2004-10-07
text: Considered as unfinished business. (consideration: CR H8650-8651)
action_date: 2004-10-06
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2004-10-06
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 5213.
action_date: 2004-10-06
text: Considered under suspension of the rules. (consideration: CR H8255-8257)
action_date: 2004-10-06
text: Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
action_date: 2004-10-05
text: Referred to the Subcommittee on Health.
action_date: 2004-10-05
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2004-10-05
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2004-10-05
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2004-10-05
text: Introduced in House
action_date: 2004-10-05
text: Introduced in House

Enacted as: number: 108-427